Cargando…
Current topics in iPSCs technology /
"[A]ddresses the progress in induced pluripotent stem cell technologies. Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by the expression of specific transcription factors. These cells are transforming biomedical research in the last 15 years. The volume teaches r...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; San Diego, CA :
Academic Press,
[2022]
|
| Colección: | Advances in stem cell biology ;
v. 17. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1293025471 | ||
| 003 | OCoLC | ||
| 005 | 20231120010628.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 220123t20222022enka ob 001 0 eng d | ||
| 040 | |a YDX |b eng |e rda |e pn |c YDX |d YDXIT |d OCLCO |d OPELS |d OCLCO |d OCLCF |d OCLCQ |d EBLCP |d N$T |d UKMGB |d UKAHL |d SFB |d WAU |d OCLCO | ||
| 015 | |a GBC1I6342 |2 bnb | ||
| 016 | 7 | |a 020387606 |2 Uk | |
| 019 | |a 1292974468 |a 1293260878 |a 1308523983 |a 1308537714 | ||
| 020 | |a 9780323983983 |q (electronic book) | ||
| 020 | |a 0323983987 |q (electronic book) | ||
| 020 | |z 9780323998925 |q (paperback) | ||
| 020 | |z 0323998925 |q (paperback) | ||
| 035 | |a (OCoLC)1293025471 |z (OCoLC)1292974468 |z (OCoLC)1293260878 |z (OCoLC)1308523983 |z (OCoLC)1308537714 | ||
| 050 | 4 | |a QH588.I63 |b C87 2022 | |
| 082 | 0 | 4 | |a 616.02/774 |2 23 |
| 245 | 0 | 0 | |a Current topics in iPSCs technology / |c edited by Alexander Birbrair. |
| 264 | 1 | |a London ; |a San Diego, CA : |b Academic Press, |c [2022] | |
| 264 | 4 | |c �2022 | |
| 300 | |a 1 online resource (xxix, 605 pages) : |b color illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 340 | |g polychrome |2 rdacc | ||
| 340 | |g color | ||
| 340 | |p illustration |2 rdaill | ||
| 490 | 1 | |a Advances in stem cell biology ; |v volume 17 | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Regulatory and policy considerations in iPSC research / Geoffrey P. Lomax -- hiPSCs for population genetics / Zhifen Chen, Shi Su and Chad A. Cowan -- Using human induced pluripotent stem cells to advanced personalized/precision medicine / Sandra L. Leibel, Rachael N. McVicar, Anne Bush and Evan Y. Snyder -- hiPSC disease modeling with 3D organoids : bioengineering perspective / Nathan James Cunningham, Rahulkumar Bhoi and Huaxiao Yang -- The differentiation of embryonic stem cells and induced pluripotent stem cells into airway and aveolar epithelial cells / Martin H. Kang and Bernard Th�ebaud -- Transplantation of human iPSC-derived kidney organoids / Yong Kyun Kim and Benjamin S. Freedman -- An update on clinical applications of iPSCs from a genomic point of view / Masahito Yoshihara and Yasuhiro Murakawa -- Replication-associated DNA damage in induced pluripotent stem cells / Haritha Vallabhaneni and Deborah A. Hursh -- Epigenetic modifications in induced pluripotent stem cells to boost myogenic commitment / Natacha Breuls, Nefele Giarratana, Laura Yedigaryan and Maurilio Sampaolesi -- Applications for induced pluripotent stem cells in reproductive medicine / Andr�ee Gauthier-Fisher, Miriel S.H. Ho, Mirabelle S.H. Ho, Dan Nir and Clifford L. Librach -- iPSCs in insulin resistance, type 2 diabetes, and the metabolic syndrome / Ivan Carcamo-Orive -- Induced pluripotent stem cells for cystic fibrosis / Onofrio Laselva and Massimo Conese -- Exploring 15q13.3 copy number variants in iPSCs / Madelyn A. Gillentine -- Human induced pluripotent stem cells for modeling Brugada syndrome / Ibrahim El-Battrawy, Siegfried Lang, Jacqueline Kowitz, Xiaobo Zhou and Ibrahim Akin -- iPSCs for erythromycin arrhythmogenicity testing / A.D. Podgurskaya, M.M. Slotvitsky, V.A. Tsvelaya and K.I. Agladze -- Therapeutic potential of induced pluripotent stem cell-derived extracellular vesicles : Quo Vadis? Terra incognito / Mirabelle S.H. Ho, Miriel S.H. Ho and Clifford L. Librach -- Proteomic approach for creation of the protein marker panels to control the quality of human induced pluripotent stem cells / Natalia Pripuzova, Melkamu Getie-Kebtie, Christopher Grunseich, Colin Sweeney and Michail A. Alterman -- Application of induced pluripotent stem cells in tissue engineering / Sadegh Iotfalah Moradi, Maryam Mahmoodinia Maymand and Abdolreza Ardeshirylajimi -- Induced pluripotent stem cell-derived extracellular vesicles in regenerative medicine / Evgeniya A. Vaskova, Ji Hye Jung, Connor G. O'Brien, Gentaro Ikeda and Phillip C. Yang -- iPSCs and toxicology : predictive tool for present and future / Alessia Bertero, Teresa Coccini and francesca Caloni -- Rejuvenation through iPSCs and reprogramming in vivo and in vitro / Andrew R. Mendelsohn, Anna R. Mendelsohn and Jennifer Lei. | |
| 520 | |a "[A]ddresses the progress in induced pluripotent stem cell technologies. Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by the expression of specific transcription factors. These cells are transforming biomedical research in the last 15 years. The volume teaches readers about current advances in the field. This book describes different technologies and strategies to use induced pluripotent stem cells for biological and clinical benefits. In recent years, remarkable progress has been made in the obtention of induced pluripotent stem cells and their differentiation into several cell types, tissues, and organs using state-of-art techniques. These advantages facilitated identification of key targets and definition of the molecular basis of several disorders. This volume is written for researchers and scientists interested in stem cell therapy, cell biology, regenerative medicine, and organ transplantation; and is contributed by world-renowned authors in the field"--Print version, page 4 of cover. | ||
| 588 | 0 | |a Online resource; title from digital title page (viewed on January 26, 2022). | |
| 650 | 0 | |a Induced pluripotent stem cells. | |
| 650 | 0 | |a Induced pluripotent stem cells |x Therapeutic use. | |
| 650 | 0 | |a Mesenchymal stem cells. | |
| 650 | 0 | |a Stem cells |x Therapeutic use. | |
| 650 | 6 | |a Cellules souches m�esenchymateuses. |0 (CaQQLa)000284363 | |
| 650 | 6 | |a Cellules souches |0 (CaQQLa)201-0058821 |x Emploi en th�erapeutique. |0 (CaQQLa)201-0373975 | |
| 650 | 7 | |a Induced pluripotent stem cells |2 fast |0 (OCoLC)fst02061264 | |
| 700 | 1 | |a Birbrair, Alexander, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Current topics in iPSCs technology. |d London, United Kingdom : Academic Press, an imprint of Elsevier, [2022] |z 9780323998925 |w (OCoLC)1285704185 |
| 830 | 0 | |a Advances in stem cell biology ; |v v. 17. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780323998925 |z Texto completo |